Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.535, 2007-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adjuvant trastuzumab promising but costly for breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 500, 2006-01 ,pp. :
Access to resources
Recommend
Indirect costs lower with raltitrexed
Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. :
Indirect costs of heart disease
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 263, 2000-01 ,pp. :
Indirect costs lower with raltitrexed
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 267, 2000-01 ,pp. :
Costs and Benefits of Genomics Patents
American Journal of PharmacoGenomics, Vol. 4, Iss. 5, 2004-01 ,pp. :